Los puntos clave no están disponibles para este artículo en este momento.
After selling their last company, Prometheus Therapeutics, to Merck other investors include OrbiMed, Fidelity Investments, and Sanofi's venture arm.
Rowan Walrath (Mon,) studied this question.